• Exchange: LSE EuropeQS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

IPN:LI

37.725 EUR 1.065 2.91%

As of 11:22:58 ET on 10/22/2014.

Snapshot for Ipsen SA (IPN)

Open: 36.545 Day's Range: 36.545 - 37.725 Volume: 0
Previous Close: 36.660 52wk Range: 28.275 - 40.105 1-Yr Rtn: +23.61%

Stock Chart for IPN

No chart data available.
  • IPN:LI 37.690
  • 1D
  • 1M
  • 1Y
36.660
Interactive IPN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IPN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.8116
Relative P/E vs. UKX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.1180
Est. PEG Ratio 1.5982
Market Cap (M EUR) 3,122.92
Shares Outstanding (M) 82.78
30 Day Average Volume 789
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.12%
Cash Dividend (EUR) 0.8000
Dividend Ex-Date 06/09/2014
5 Year Dividend Growth -
Next Earnings Announcement 02/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IPN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for IPN

Ipsen SA manufactures and markets a wide range of medical drugs for targeted disease areas including oncology, endocrinology, and neuromuscular disorders.

Marc De GaridelChairman/CEOChristel BoriesDeputy CEO
Susheel SurpalExec VP/CFONathalie JoannesExec VP/General Counsel
More Company Profile & Key Executives for IPN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil